Home›Companies›Healthcare›CSI

Contamination Source Identification Inc.

Provides physicians with tests to identify pathogens in patient samples.

Updated Nov 10, 2026·Latest SEC filing Apr 9, 2026·Suggest an edit

About CSI

CSI is a private company based in Hershey, Pennsylvania. It has reported $4,128,000 raised in three offerings on Form D since January 2020. Its chief executive is Gary Shope.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 19, 2023May 2, 2023amended Apr 9, 2026$2,095,000of $2.5M target16$130KDebt, Securities on exerciseRule 506(b)Form D/A ↗3 earlier filings
Not yetAug 23, 2022$0of $1.0M target0—Debt, Securities on exerciseRule 506(b)Form D ↗
Apr 5, 2019Jan 16, 2020amended Jan 21, 2022$2,033,000of $3.0M target18$112KDebt, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Total, three offerings$4,128,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on CSI's Form D filed Apr 9, 2026.

RH
Randy Haluck
Director
GS
Gary Shope
Chief Executive Officer and director
GP
Gautam Patel
Director
TS

Earlier filings also listed Timothy Breya (executive officer, last listed Aug 2022), Regina Lamendella (director, last listed Aug 2022), Justin Wright (director, last listed Aug 2022), Alexander Shope (executive officer, last listed Aug 2022) and Shannon McCombie (executive officer, last listed Jan 2022).

Sources

  1. SECContamination Source Identification Inc. Form D/A, filed Apr 21, 2025
  2. SECContamination Source Identification Inc. Form D/A, filed Apr 29, 2024
  3. SECContamination Source Identification Inc. Form D, filed May 2, 2023
  4. SECContamination Source Identification Inc. Form D/A, filed Jan 19, 2021
  5. SECContamination Source Identification Inc. Form D, filed Jan 16, 2020
  6. SECContamination Source Identification Inc. filing history